A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

NCT02337764 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
222
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda